The Democratic Republic of the Congo (#DRC) will receive Ervebo vaccines from the global Ebola virus disease vaccine stockpile for use in the current Bundibugyo virus disease outbreak. The Ervebo vaccine is licensed and recommended for use in outbreaks of Ebola virus (previously known as Zaire ebolavirus) disease. The current allocation includes 20 000 doses for a Phase 3 clinical trial to understand the impact of the vaccine on the Bundibugyo virus, and 50 000 doses for frontline and health wo